Androfen Calculations Off Target For Reasonable Interpretations Of Claim – ERSP
This article was originally published in The Tan Sheet
Executive Summary
Androfen should discontinue claims its testosterone-boosting supplement can “reduce body fat by over 200%” because consumers can interpret it in a way that is not supported, ERSP says. The firm can continue to claim the fenugreek product enhances libido and promotes body fat loss.